No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
Abstract Type I interferons act as gatekeepers against viral infection, and autoantibodies that neutralize these signaling molecules have been associated with COVID-19 severity and adverse reactions to the live-attenuated yellow fever vaccine. On this background, we sought to examine whether autoant...
Main Authors: | Ahmet Yalcinkaya, Marco Cavalli, Axel Cederholm, Maribel Aranda-Guillén, Anish Behere, Hedvig Mildner, Tadepally Lakshmikanth, Laura Gonzalez, Constantin Habimana Mugabo, Anette Johnsson, Olov Ekwall, Olle Kämpe, Sophie Bensing, Petter Brodin, Pär Hallberg, Mia Wadelius, Nils Landegren |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-024-00829-9 |
Similar Items
-
Whole genome case-control study of central nervous system toxicity due to antimicrobial drugs.
by: Joel Ås, et al.
Published: (2024-01-01) -
Increasing Melanoma—Too Many Skin Cell Damages or Too Few Repairs?
by: Örjan Hallberg, et al.
Published: (2013-02-01) -
Solitary form of nevus lipomatosus cutaneous superficialis: A rare entity with review of literature
by: Krishna Tadepally, et al.
Published: (2017-01-01) -
Molecular tools to monitor health and disease – and lucky coincidences
by: Ulf Landegren
Published: (2022-10-01) -
Reduced obstacles, maximized vision (ROMV): a new technique to facilitate laryngoscopy for endotracheal intubation
by: Mohammad Kharazmi, et al.
Published: (2017-01-01)